These outcomes, together with a earlier report displaying that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,2 guidance the concept of focusing on ACKR3 as a unique technique to modulate the opioid program, which could open new therapeutic avenues for opioid-relevant Conditions. The supplement is intended working https://paull581sfo7.csublogs.com/profile